PERSISTENCY BONUS QUALIFIER Sample Clauses

PERSISTENCY BONUS QUALIFIER. A. Minimum of 251 enrolled medical contracts; B. Net overall growth in the number of Insurer contracts subject to this Agreement as measured by the difference between the contracts on the Beginning Date of business with Insurer subject to this contract and those contracts in effect on December 31, 2013. New Business is included in Persistency Bonus calculation and ratio described above. C. Insurer shall have the authority to determine qualifications and final ratios for any qualifying Broker/Agent. D. When two blocks of business merge, the new basis for the Persistency Bonus becomes the start number from both blocks as of January 1st of the year of the merger. All terminations/additions from both blocks combine into the new block. E. USAble Life/Disability Premium Persistency Bonus Qualifier 1. Must already have a 95.0% persistency to achieve additional medical contract equivalents. 2. For each $100,000 of annualized USAble Premium sold an additional 25 Medical contracts will be added to your 2013 Eligible Medical contract counts. 3. The additional contract counts earned for 2013 USAble Premiums do not rollover to 2014. 4. Payment rate for the additional contacts earned will be at the rate based on the Medical Bonus Payout Scale.
AutoNDA by SimpleDocs
PERSISTENCY BONUS QUALIFIER. 1. Minimum of $2,100,000.00 in annual Group Insurer paid premium; 2. Minimum Persistency Ratio of 85% - measured by the number of contracts in force with Insurer on December 31, 2007, for an existing contracted broker or the first day on which a new Broker wrote business subject to this Agreement (the "Beginning Date") compared to the number of contracts in those same groups on December 31, 2008, 3. Net overall growth in the number of Insurer contracts subject to this Agreement as measured by the difference between the contracts on the Beginning Date of business with Insurer subject to this contract and those contracts in effect on December 31, 2008. 4. New Business is not included in Persistency Bonus calculation or ratio described in (2) above. New Business is included in Persistency Bonus calculation and ratio described in (3) above.
PERSISTENCY BONUS QUALIFIER. A. Minimum of 251 enrolled medical contracts; B. Net overall growth in the number of Insurer contracts subject to this Agreement as measured by the difference between the contracts on the Beginning Date of business with Insurer subject to this contract and those contracts in effect on December 31, 2011. New Business is included in Persistency Bonus calculation and ratio described above. C. Insurer shall have the authority to determine qualifications and final ratios for any qualifying Broker/Agent. D. When two blocks of business merge, the new basis for the Persistency Bonus becomes the start number from both blocks as of January 1st of the year of the merger. All terminations/additions from both blocks combine into the new block.
PERSISTENCY BONUS QUALIFIER. A. Minimum of 251 enrolled medical subscriber contracts; B. Net overall growth in the number of Insurer contracts subject to this Agreement as measured by the difference between the contracts on the Beginning Date of business with Insurer subject to this contract and those contracts in effect on December 31, 2015. New Business is included in Persistency Bonus calculation and ratio described above. C. Insurer shall have the authority to determine qualifications and final ratios for any qualifying Broker/Agent. D. When two blocks of business merge, the new basis for the Persistency Bonus becomes the start number from both blocks as of January 1st of the year of the merger. All terminations/additions from both blocks combine into the new block. X. Xxxxxx/Agents that lose accounts sized 100+ from their block of business that Insurer retains, can request in writing that Insurer remove these accounts from Broker/Agent annual beginning block of business total for bonus calculation purposes. X. Xxxxxx/Agents existing subscriber contracts that transfer/atomizes or transfers into the Insurer’s Consumer Direct market will be removed from Broker/Agents annual beginning block of business total for bonus calculation purposes. G. USAble Life/Disability Premium Persistency Bonus Qualifier 1. Must already have a 90.0% persistency to achieve additional medical contract equivalents. 2. For each $100,000 of annualized USAble Premium sold an additional 40 Medical contracts will be added to your 2015 Eligible Medical contract counts. 3. The additional contract counts earned for 2015 USAble Premiums do not rollover to 2016. 4. Payment rate for the additional contacts earned will be at the rate based on the Medical Bonus Payout Scale.

Related to PERSISTENCY BONUS QUALIFIER

  • Longevity Bonus After twenty (20) years of continuous service, an employee will receive a longevity bonus of seven hundred dollars ($700) per year, payable in one lump sum by the second pay period following the employee's anniversary date.

  • Annual Cash Bonus During the Term, Executive may be eligible to receive an annual cash bonus, on terms and conditions as determined by the Committee in its sole discretion taking into account Company and individual performance objectives.

  • Automatic Renewal Limitation for TIPS Sales No TIPS Sale may incorporate an automatic renewal clause that exceeds month to month terms with which the TIPS Member must comply. All renewal terms incorporated into a TIPS Sale Supplemental Agreement shall only be valid and enforceable when Vendor received written confirmation of acceptance of the renewal term from the TIPS Member for the specific renewal term. The purpose of this clause is to avoid a TIPS Member inadvertently renewing an Agreement during a period in which the governing body of the TIPS Member has not properly appropriated and budgeted the funds to satisfy the Agreement renewal. Any TIPS Sale Supplemental Agreement containing an “Automatic Renewal” clause that conflicts with these terms is rendered void and unenforceable.

  • Performance Goal (a) Subject to the following sentence, the Performance Goal is set out in Appendix A hereto, which Appendix A is incorporated by reference herein and made a part hereof. Notwithstanding the foregoing, the provisions of Section 13 or any other provision of this Agreement to the contrary, the Committee reserves the right to unilaterally change or otherwise modify the Performance Goal in any manner whatsoever (including substituting a new Performance Goal). If the Committee exercises such discretionary authority to any extent, the Committee shall provide the Grantee with a new Appendix A in substitution for the Appendix A attached hereto, and such new Appendix A and the Performance Goal set out therein (rather than the Appendix A attached hereto and the Performance Goal set out therein) shall in all events apply for all purposes of this Agreement. (b) Depending upon the extent, if any, to which the Performance Goal has been achieved, and subject to compliance with the requirements of Section 4, each PSU shall entitle the Grantee to receive, at such time as is determined in accordance with the provisions of Section 5, between 0 and 2.0 Shares for each PSU. The Committee shall, as soon as practicable following the last day of the Performance Period, certify (i) the extent, if any, to which, in accordance with Appendix A, the Performance Goal has been achieved with respect to the Performance Period and (ii) the number of whole and/or partial Shares, if any, which, subject to compliance with the vesting requirements of Section 4, the Grantee shall be entitled to receive with respect to each PSU (with such number of whole and/or partial Shares being hereafter referred to as the “Share Delivery Factor”). Such certification shall be final, conclusive and binding on the Grantee, and on all other persons, to the maximum extent permitted by law.

  • Performance Adjustment One-twelfth of the annual Performance Adjustment Rate will be applied to the average of the net assets of the Portfolio (computed in the manner set forth in the Fund's Declaration of Trust or other organizational document) determined as of the close of business on each business day throughout the month and the performance period.

  • Performance Pay In accordance with Section 8 of the General Appropriations Act for Fiscal Year 2020-2021, contingent upon the availability of funds and at the Agency Head’s discretion, each agency is authorized to grant merit pay increases based on the employee’s exemplary performance, as evidenced by a performance evaluation conducted pursuant to Rule 60L-35, Florida Administrative Code.

  • Performance Measurement The Uniform Guidance requires completion of OMB-approved standard information collection forms (the PPR). The form focuses on outcomes, as related to the Federal Award Performance Goals that awarding Federal agencies are required to detail in the Awards.

  • Performance Bonus The Executive shall be eligible to receive an annual performance bonus, payable within sixty (60) days after the end of the fiscal year of the Employer, in an amount not to exceed twenty-five percent (25%) of the Executive's Base Salary for the applicable year. The amount, if any, shall be determined by the Board, or the appropriate committee thereof, and shall generally be based on a combination of organization-wide and individual performance criteria.

  • Annual Performance Bonus During the Employment Term, the Executive shall be entitled to participate in the STIP, with such opportunities as may be determined by the Chief Executive Officer in his sole discretion (“Target Bonuses”), and as may be increased (but not decreased, except for across-the-board reductions generally applicable to the Company’s senior executives) from time to time, and the Executive shall be entitled to receive full payment of any award under the STIP, determined pursuant to the STIP (a “Bonus Award”).

  • Covenants of Performance Measurement No interference. Registry Operator shall not interfere with measurement Probes, including any form of preferential treatment of the requests for the monitored services. Registry Operator shall respond to the measurement tests described in this Specification as it would to any other request from an Internet user (for DNS and RDDS) or registrar (for EPP). ICANN testing registrar. Registry Operator agrees that ICANN will have a testing registrar used for purposes of measuring the SLRs described above. Registry Operator agrees to not provide any differentiated treatment for the testing registrar other than no billing of the transactions. ICANN shall not use the registrar for registering domain names (or other registry objects) for itself or others, except for the purposes of verifying contractual compliance with the conditions described in this Agreement. PUBLIC INTEREST COMMITMENTS Registry Operator will use only ICANN accredited registrars that are party to the Registrar Accreditation Agreement approved by the ICANN Board of Directors on 27 June 2013 in registering domain names. A list of such registrars shall be maintained by ICANN on ICANN’s website. (Intentionally omitted. Registry Operator has not included commitments, statements of intent or business plans provided for in its application to ICANN for the TLD.) Registry Operator agrees to perform the following specific public interest commitments, which commitments shall be enforceable by ICANN and through the Public Interest Commitment Dispute Resolution Process established by ICANN (posted at xxxx://xxx.xxxxx.xxx/en/resources/registries/picdrp), which may be revised in immaterial respects by ICANN from time to time (the “PICDRP”). Registry Operator shall comply with the PICDRP. Registry Operator agrees to implement and adhere to any remedies ICANN imposes (which may include any reasonable remedy, including for the avoidance of doubt, the termination of the Registry Agreement pursuant to Section 4.3(e) of the Agreement) following a determination by any PICDRP panel and to be bound by any such determination. Registry Operator will include a provision in its Registry-Registrar Agreement that requires Registrars to include in their Registration Agreements a provision prohibiting Registered Name Holders from distributing malware, abusively operating botnets, phishing, piracy, trademark or copyright infringement, fraudulent or deceptive practices, counterfeiting or otherwise engaging in activity contrary to applicable law, and providing (consistent with applicable law and any related procedures) consequences for such activities including suspension of the domain name. Registry Operator will periodically conduct a technical analysis to assess whether domains in the TLD are being used to perpetrate security threats, such as pharming, phishing, malware, and botnets. Registry Operator will maintain statistical reports on the number of security threats identified and the actions taken as a result of the periodic security checks. Registry Operator will maintain these reports for the term of the Agreement unless a shorter period is required by law or approved by ICANN, and will provide them to ICANN upon request. Registry Operator will operate the TLD in a transparent manner consistent with general principles of openness and non-discrimination by establishing, publishing and adhering to clear registration policies.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!